PTC Therapeutics, Inc. (PTCT)
NMS – Real Time Price. Currency in USD
73.04
-0.66 (-0.90%)
Market open: Aug 12, 2026, 1:40 PM EDT
73.70
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
73.04
-0.66 (-0.90%)
Market open: Aug 12, 2026, 1:40 PM EDT
73.70
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $1.0B significantly exceed its total debt $696.5M, ensuring strong financial flexibility
Total current assets $2.6B exceed Total current liabilities $771.1M, highlighting excellent liquidity
Debt-to-equity ratio (-4.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (3x) is sufficient but not particularly strong
The company generates positive free cash flow $126.9M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.39 | 6.05 | 10 | |
| Quick ratio | 3.28 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.21 | 1.04 | 7.0 | |
| Interest coverage | 3.07 | -16.91 | 8.0 | |
| Weighted average score | 7.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 699M | 938M | 807M | 1.73B | 1.01B |
| Gross Profit | 538M | 650M | 689M | 1.66B | 898M |
| Operating Income | -440M | -349M | -147M | 857M | 117M |
| Net Income | -559M | -627M | -363M | 683M | -38M |
| EBITDA | -311M | -113M | -71M | 895M | 172M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 46.55 | 103.61 | 10 |
| Next quarter | 94.85 | 117.51 | 10 |
| Current year | -27 | -81.6 | 1.0 |
| Next year | 7.79 | 92.96 | 8.0 |
| Weighted average score | 7.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 32.28 | 3072.45 | 3166.67 | 310.7 | 10 |
| Y/Y | 101.55 | 228.75 | 210.84 | 313.03 | 10 |
| 3y average | 44.92 | 105.95 | 100.18 | 268.62 | 10 |
| 5y average | 41.19 | 58.32 | 56.76 | 146.99 | 10 |
| Weighted average score | 10 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |